Plastic and Aesthetic Research
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Plastic and Aesthetic Research
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig1

From:  Patient-centric dose equivalency pilot study of incobotulinumtoxin a (xeomin) vs. abobotulinumtoxin a (dysport) in the treatment of glabellar frown lines
Patient-centric dose equivalency pilot study of incobotulinumtoxin a (xeomin) <i>vs</i>. abobotulinumtoxin a (dysport) in the treatment of glabellar frown lines

Figure 1. Neuromodulator dose ratio vs. muscle activity (percent) at 10-12 weeks

Plastic and Aesthetic Research
ISSN 2349-6150 (Online)   2347-9264 (Print)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/plastic-and-aesthetic-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/plastic-and-aesthetic-research

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties